Myrexis, Inc. (MYRX)

Market Cap	27.58K -98.1%
Revenue (ttm)	n/a
Net Income	-11.62M
EPS	-0.39
Shares Out	34.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	150
Open	0.0008
Previous Close	0.0008
Day's Range	0.0008 - 0.0008
52-Week Range	0.0001 - 0.0050
Beta	3.60
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Myrexis

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

• Industry: Shell Companies
• Sector: Financials
• CEO: Jonathan Couchman
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: MYRX

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 15, 2026

Data Sources Report a data error